Lung and Heart Transplants From HCV-Infected Donors: Expert Roundtable
Further patient advocacy is needed to ensure that recipients of HCV-infected organs have access to direct-acting antivirals as early as possible, including in a prophylactic manner, if data continue to support its benefit.
